Fibrocalculous pancreatopathy

From WikiMD's WELLNESSPEDIA

Fibrocalculous Pancreatopathy (FCP) is a form of tropical calcific pancreatitis that is unique to developing countries. It is characterized by the presence of calcification in the pancreas, leading to diabetes mellitus and malnutrition.

Etiology[edit]

The exact cause of FCP is unknown, but it is believed to be multifactorial. Some researchers suggest that the disease may be caused by a combination of genetic and environmental factors. The consumption of a diet high in cassava, which contains cyanogenic glycosides, has been implicated in some cases.

Pathophysiology[edit]

In FCP, the pancreas undergoes fibrosis and calcification, leading to the destruction of the exocrine and endocrine functions of the organ. This results in malnutrition due to the lack of digestive enzymes and diabetes mellitus due to the loss of insulin production.

Clinical Presentation[edit]

Patients with FCP typically present in childhood or adolescence with symptoms of malnutrition and diabetes mellitus. These may include polyuria, polydipsia, and unexplained weight loss. In severe cases, patients may also present with steatorrhea due to the lack of pancreatic enzymes.

Diagnosis[edit]

The diagnosis of FCP is made based on clinical presentation, imaging studies, and laboratory tests. Computed tomography (CT) or ultrasound of the abdomen may show calcification in the pancreas. Laboratory tests may reveal elevated blood glucose levels and low levels of pancreatic enzymes in the stool.

Treatment[edit]

The treatment of FCP is primarily supportive and includes nutritional supplementation and insulin therapy. In severe cases, pancreatic enzyme replacement therapy (PERT) may be required. There is currently no cure for FCP.

Prognosis[edit]

The prognosis of FCP is poor, with most patients developing diabetes mellitus and malnutrition. However, with appropriate management, the progression of the disease can be slowed and the quality of life can be improved.

See Also[edit]




This tropical disease related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.